Chika Fujii

Sakai, 5938304, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Troxipide nanosuspensions prevent indomethacin‑induced gastrointestinal lesions in adjuvant-induced arthritis rats.

Troxipide nanosuspensions prevent indomethacin‑induced gastrointestinal lesions in adjuvant-induced arthritis rats.

Journal: Journal of pharmaceutical health care and sciences

Published: November 01, 2025

Administration Period of Olanzapine as an Antiemetic Drug for Patients on FEC Therapy-A Survey

Administration Period of Olanzapine as an Antiemetic Drug for Patients on FEC Therapy-A Survey

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: July 08, 2022

Proteinuria in Patients with Gastric Cancer Treated with Ramucirumab

Proteinuria in Patients with Gastric Cancer Treated with Ramucirumab

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: March 28, 2019

Eye Disorders Associated with S-1 Chemotherapy in Gastric Cancer Patients

Eye Disorders Associated with S-1 Chemotherapy in Gastric Cancer Patients

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: January 31, 2017

Clinical Experience of Ramucirumab for Treating Advanced Gastric Cancer

Clinical Experience of Ramucirumab for Treating Advanced Gastric Cancer

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: October 21, 2016

Efficacy of AboundTM for hand-foot syndrome caused by capecitabine

Efficacy of AboundTM for hand-foot syndrome caused by capecitabine

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: January 08, 2014

A case report of advanced gastric cancer with increased C-reactive protein(CRP) and decreased albumin levels: chemotherapy with nutritional supportive care using eicosapentaenoic acid (EPA)-enriched enteral nutrition agent

A case report of advanced gastric cancer with increased C-reactive protein(CRP) and decreased albumin levels: chemotherapy with nutritional supportive care using eicosapentaenoic acid (EPA)-enriched enteral nutrition agent

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: December 27, 2012

The feasibility of CDDP administration for gastric cancer outpatients undergoing S-1/cisplatin combination therapy

The feasibility of CDDP administration for gastric cancer outpatients undergoing S-1/cisplatin combination therapy

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: December 27, 2012

Evaluation of outpatient clinical pathway, including the supportive therapy of S-1+cisplatin combination therapy for gastric cancer

Evaluation of outpatient clinical pathway, including the supportive therapy of S-1+cisplatin combination therapy for gastric cancer

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: December 27, 2012

Examination of factors influencing continuity of S-1 adjuvant chemotherapy for gastric cancer patients

Examination of factors influencing continuity of S-1 adjuvant chemotherapy for gastric cancer patients

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: August 21, 2012

Gastrojejunostomy followed by chemotherapy with S-1 in unresectable gastric cancer with pyloric stenosis

Gastrojejunostomy followed by chemotherapy with S-1 in unresectable gastric cancer with pyloric stenosis

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: June 19, 2012

Assessment of nausea and vomiting during FEC regimen for breast cancer after the novel antiemetic agent - introduction using MASCC antiemesis tool

Assessment of nausea and vomiting during FEC regimen for breast cancer after the novel antiemetic agent - introduction using MASCC antiemesis tool

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: February 16, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026